Rick Bowers
Child & Adolescent Psychiatry · Moraine, OHNPI 1396784450
Payments from drug & device makers
Across 1,041 payments — averaging $175.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$108K
- Supernus Pharmaceuticals, Inc.$56K
- Teva Pharmaceuticals USA, Inc.$7K
- Alkermes, Inc.$2K
- Otsuka America Pharmaceutical, Inc.$1K
- Johnson & Johnson$1K
- plus $6K from 22 others
What the payments were for
- Speaking & faculty fees$150,55483%
- Travel & lodging$10,5086%
- Food & beverage$21,09512%
- Education$1020%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 255 | $108,324 |
| Supernus Pharmaceuticals, Inc. | 137 | $55,693 |
| Teva Pharmaceuticals USA, Inc. | 70 | $6,969 |
| Alkermes, Inc. | 119 | $2,233 |
| Otsuka America Pharmaceutical, Inc. | 68 | $1,491 |
| Johnson & Johnson | 52 | $1,300 |
| AbbVie(2 entities) | 52 | $926 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 51 | $916 |
| Sunovion Pharmaceuticals Inc. | 39 | $628 |
| Neurocrine Biosciences, Inc. | 33 | $594 |
| Axsome Therapeutics, Inc. | 19 | $594 |
| Corium, LLC | 37 | $539 |
| Lundbeck LLC | 30 | $498 |
| E.r. Squibb & Sons, L.L.C. | 26 | $432 |
| Vanda Pharmaceuticals Inc. | 15 | $392 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $192 |
| Indivior Inc. | 7 | $118 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $72 |
| Noven Therapeutics, LLC | 5 | $68 |
| Idorsia Pharmaceuticals US Inc | 1 | $66 |
| Collegium Pharmaceutical, Inc. | 3 | $47 |
| Vertical Pharmaceuticals, LLC | 2 | $30 |
| Tempus AI, Inc | 2 | $30 |
| Tris Pharma Inc | 2 | $29 |
| Braeburn Inc. | 1 | $26 |
| Neuronetics, Inc. | 1 | $22 |
| Cognoa, Inc. | 1 | $19 |
| Shire North American Group Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$182,259 in reported general payments places this provider in the 95th percentile of 160 child & adolescent psychiatry providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 13 | $88,853 |
| IngrezzaValbenazine Tosylate | 11 | $87,757 |
| CaplytaLumateperone Tosylate | 24 | $38,690 |
| LybalviOlanzapine/Samidorphan Malate | 13 | $18,351 |
| Clozapine OdtClozapine | 26 | $9,011 |
| Topiramate | 23 | $998 |
| Guanfacine Hcl ErGuanfacine Hcl | 14 | $892 |
| Ziprasidone Hcl | 11 | $783 |
| Glycopyrrolate | 11 | $469 |
| Trazodone Hcl | 47 | $407 |
| Fluoxetine Hcl | 11 | $279 |
| Methylphenidate Hcl | 11 | $76 |
| Metformin Hcl | 20 | $69 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $6,969 | $88,85313 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $594 | $87,75711 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $916 | $38,69024 claims |
| Alkermes, Inc.Lybalvi | $2,233 | $18,35113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 160 child & adolescent psychiatry providers in Ohio.
Other child & adolescent psychiatry in Moraine
- Melissa DelbelloCincinnati$4.5M
- Luis Patino DuranCincinnati$652K
- Nora McNamaraCleveland$567K
- Robert FindlingCleveland$421K
- Craig EricksonCincinnati$275K
- Ernest PedapatiCincinnati$257K
- Lawrence ArnoldColumbus$215K
- Kelli DominickCincinnati$175K
- Amy Hoisington-StabileColumbus$121K
- Ghada LteifColumbus$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.